InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-9.0%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by BRYANT DOUGLAS C, Chairman & CEO. Director active across 2 companies, notably QUIDEL CORP. In total, 23 reports have been logged. History available since 24 August 2021. The latest transaction was filed on 1 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations23 total
1,116 shares0Common StockSEC:0000950170-24-011463:0
6,761 shares0Common StockSEC:0000950170-24-010870:0
1,461 shares0Common StockSEC:0001209191-23-047501:0
15,180 shares0Common StockSEC:0001209191-23-013176:0
7,309 shares0Common StockSEC:0001209191-23-009166:0
3,795 shares0Common StockSEC:0001209191-23-007502:0
1,882 shares@ US$89.7016.9% of flowCommon StockSEC:0001209191-23-007502:1
18,720 shares0Common StockSEC:0001209191-23-007502:2
9,282 shares@ US$89.7083.1% of flowCommon StockSEC:0001209191-23-007502:3
6,760 shares0Common StockSEC:0001209191-23-006320:0
1,460 shares0Common StockSEC:0001209191-22-047699:0
505,926 sharesCommon StockSEC:0000899243-22-020387:0
505,926 sharesCommon StockSEC:0000899243-22-020508:0
3,795 shares0Common StockSEC:0001209191-22-007618:0
3,795 shares0Common StockSEC:0001209191-22-007617:0
3,795 shares0Common StockSEC:0001209191-22-007617
3,795 shares0Common StockSEC:0001209191-22-007618
1,115 shares0Common StockSEC:0001209191-22-006631:0
1,115 shares0Common StockSEC:0001209191-22-006631
13,819 shares0Common StockSEC:0001209191-22-003870:0
13,819 shares0Common StockSEC:0001209191-22-003870
1,460 shares0Common StockSEC:0001209191-21-053551:0
1,460 shares0Common StockSEC:0001209191-21-053551
23 of 23 declarations
About BRYANT DOUGLAS C
Douglas C. Bryant is the Chairman and CEO of QUIDEL CORP /DE/ and QuidelOrtho Corp. He is responsible for the strategic direction and management of operations for both companies. With extensive experience in the healthcare sector, he plays a key role in optimizing services and customer engagement. His leadership focuses on sustainable growth and innovation in the diagnostics industry.
